|

HRS-1358 Clinical Trials

2 actively recruiting trials

Pipeline

Phase 1: 1Phase 1/2: 1

Top Sponsors

  • Shandong Suncadia Medicine Co., Ltd.2

Indications

  • Breast Cancer2
  • Cancer2
  • Advanced Unresectable or Metastatic Breast Cancer1

Other2 trials

A Trial of HRS-1358 Tablets in Metastatic or Local Advanced Breast Cancer
Phase 1
A Trial of HRS-2189 in Combination With Fluvastatin±HRS-6209, or HRS-8080±HRS-6209, or HRS-6209+HRS-1358 in Breast Cancer Patients
Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.